[ad_1]
Posted on April 29, 2019
Expert colleagues are responding to the evidence-based benefits of using GLP-1 agonists for the treatment of type 2 diabetes and exploring the way different options work.
-
Category
- Scientific technology
Source link
Mechanisms of action of GLP-1 agonists in T2DM
Source link
